Cited by 29Heart rate and cardiovascular healthCardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmias

Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: a pooled analysis of prospective studies

Mathew, Sunil T., Po, Sunny S., Thadani, Udho·2018·Heart Rhythm

Abstract

Background Inappropriate sinus tachycardia (IST) is debilitating despite available treatment. Off-label use of ivabradine for IST prompted this systematic analysis of existing data quality and sample size estimates for adequately powered studies.Objective To determine clinical efficacy of ivabradine in IST from pooled prospective studies.Methods Analysis included ivabradine studies for IST participants without structural heart disease and with follow-up of ≥2 weeks. Heart rate and symptom reduction with ivabradine were estimated based on results of subjective change in symptoms assessed by various data instruments used in each study. Studies were assessed for quality using validated checklists. Sample sizes were calculated based on the magnitude of symptom reduction encountered after treatment with ivabradine.Results Nine studies met criteria, culminating in 145 patients pooled. Most patients were women (≥70%). Studies were small and not adequately powered, and all reported a decrease in maximum or mean resting heart rate or both, with complete or considerable amelioration of symptoms with ivabradine. Most studies had moderate quality with excellent consistency of study quality and narrow limits of agreement between the quality checklists. Sample size estimates for adequately powered studies with various placebo effects and comparisons with β-blockade are reported.Conclusions Ivabradine effectively reduces heart rate and symptoms in IST, but no study was adequately powered to account for the expected placebo effect on symptoms. A multicenter, randomized, placebo-controlled, active, comparative study with a β-blocker is needed for confirmation. This is especially relevant given the ivabradine's potential teratogenic effect, as many IST patients are females of childbearing potential.

Integrity signals

Registry

Crossref · 10.1016/j.hrthm.2017.10.004

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Properly dosed exercise training can be an effective non-pharmacologic therapeutic intervention for reversing severe muscle disuse atrophy and restoring normal exercise cardiac rate and rhythm caused by continuous bedrest in otherwise healthy adults.

    “Properly dosed exercise training can be an effective non-pharmacologic therapeutic intervention for reversing severe muscle disuse atrophy and restoring normal exercise cardiac rate and rhythm caused by a continuous period of bedrest in otherwise healthy adults192–194.”

    From Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) · cites this paper as [194]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mathew, S. T., Po, S. S., & Thadani, U.
Affiliations
  • Oklahoma City VA Medical Center (US)
  • University of Oklahoma Health Sciences Center (US)
Corresponding author
Mathew, Sunil T.
Venue
Heart Rhythm
Publisher
Elsevier BV
Published
2018-02
Volume
15
Issue
2
Pages
240-247
ISSN
1547-5271 (ISSN-L)
OpenAlex
W2761996404
Cited by
29
References
36
Citations by year
2026: 1 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 1 · 2019: 3 · 2018: 3
FWCI
0.27
Type
journal article
Language
en
Open access
closed
Locations
  • Heart Rhythm (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
inappropriate sinus tachycardia, ivabradine, heart rate reduction, symptom relief, off-label drug use, study quality assessment, sample size determination, placebo effect, beta-blockers, teratogenicity, women of reproductive age
MeSH terms
Ivabradine, Benzazepines, Cardiovascular Agents, Heart Rate, Humans, Prospective Studies, Tachycardia, Sinus, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review